Abstract
The transforming growth factor-β (TGF-β) binds the type II TGF-β growth factor receptor (RII) to inhibit the growth of most epithelial tissues. Most human colon and gastric cancers with microsatellite instability (MI) have frameshift mutations in polynucleotide repeats within the RII coding region; these mutations truncate the receptor protein and disable the serine/threonine kinase to produce TGF-β resistance. To further investigate the type, frequency and tissue distribution of RII mutations, we selected 24 human cancer cell lines from various tissues which were previously reported to be resistant to the inhibitory effects of TGF-β. We developed protocols for non-isotopic SSCP analysis of PCR products from genomic DNA samples, and we tested them for microsatellite instability. PCR – SSCP analysis followed by DNA sequencing identified deletion mutations in the exon 3 poly-adenine tract in three colon tumor cell lines: LS174T and SW48 had a single base deletion and LS411 had a two base deletion. Among the 24 previously unreported cell lines, only these three demonstrated microsatellite instability. These and other recent data indicate that RII mutations are essentially confined to colon and gastric cancers with microsatellite instability. The narrow spectrum of tissues containing RII mutations illustrates the complexity of genetic checkpoints in human carcinogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vincent, F., Nagashima, M., Takenoshita, S. et al. Mutation analysis of the transforming growth factor-β type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-β. Oncogene 15, 117–122 (1997). https://doi.org/10.1038/sj.onc.1201166
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1201166
Keywords
This article is cited by
-
Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-β1 by overexpression of cyclin D1
Laboratory Investigation (2005)
-
Establishment and characterisation of six human biliary tract cancer cell lines
British Journal of Cancer (2002)
-
Transforming growth factor-β and breast cancer: Transforming growth factor-β/SMAD signaling defects and cancer
Breast Cancer Research (2000)
-
Ras-Mediated Suppression of TGFβRII Expression in Intestinal Epithelial Cells Involves Raf-Independent Signaling
Neoplasia (2000)
-
Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines
British Journal of Cancer (1999)